• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD30 表达及其在成人 T 细胞白血病/淋巴瘤疾病进展中的作用。

CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.

机构信息

Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 1088639, Japan.

出版信息

Int J Mol Sci. 2023 May 13;24(10):8731. doi: 10.3390/ijms24108731.

DOI:10.3390/ijms24108731
PMID:37240076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10218159/
Abstract

CD30, a member of the tumor necrosis factor receptor superfamily, plays roles in pro-survival signal induction and cell proliferation in peripheral T-cell lymphoma (PTCL) and adult T-cell leukemia/lymphoma (ATL). Previous studies have identified the functional roles of CD30 in CD30-expressing malignant lymphomas, not only PTCL and ATL, but also Hodgkin lymphoma (HL), anaplastic large cell lymphoma (ALCL), and a portion of diffuse large B-cell lymphoma (DLBCL). CD30 expression is often observed in virus-infected cells such as human T-cell leukemia virus type 1 (HTLV-1). HTLV-1 is capable of immortalizing lymphocytes and producing malignancy. Some ATL cases caused by HTLV-1 infection overexpress CD30. However, the molecular mechanism-based relationship between CD30 expression and HTLV-1 infection or ATL progression is unclear. Recent findings have revealed super-enhancer-mediated overexpression at the CD30 locus, CD30 signaling via trogocytosis, and CD30 signaling-induced lymphomagenesis in vivo. Successful anti-CD30 antibody-drug conjugate (ADC) therapy for HL, ALCL, and PTCL supports the biological significance of CD30 in these lymphomas. In this review, we discuss the roles of CD30 overexpression and its functions during ATL progression.

摘要

CD30 是肿瘤坏死因子受体超家族的一员,在周围 T 细胞淋巴瘤(PTCL)和成人 T 细胞白血病/淋巴瘤(ATL)中发挥促生存信号诱导和细胞增殖的作用。先前的研究已经确定了 CD30 在表达 CD30 的恶性淋巴瘤中的功能作用,不仅在 PTCL 和 ATL 中,而且在霍奇金淋巴瘤(HL)、间变性大细胞淋巴瘤(ALCL)和部分弥漫性大 B 细胞淋巴瘤(DLBCL)中也是如此。CD30 表达通常在人类 T 细胞白血病病毒 1(HTLV-1)等病毒感染的细胞中观察到。HTLV-1 能够使淋巴细胞永生化并产生恶性肿瘤。一些由 HTLV-1 感染引起的 ATL 病例过度表达 CD30。然而,CD30 表达与 HTLV-1 感染或 ATL 进展之间基于分子机制的关系尚不清楚。最近的发现揭示了 CD30 基因座的超增强子介导的过表达、通过 trogocytosis 的 CD30 信号传导以及 CD30 信号诱导的体内淋巴瘤发生。针对 HL、ALCL 和 PTCL 的成功抗 CD30 抗体药物偶联物(ADC)治疗支持了 CD30 在这些淋巴瘤中的生物学意义。在这篇综述中,我们讨论了 CD30 过表达及其在 ATL 进展过程中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5060/10218159/44190d606356/ijms-24-08731-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5060/10218159/d0f8b4711907/ijms-24-08731-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5060/10218159/5ada8a4f77d4/ijms-24-08731-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5060/10218159/44190d606356/ijms-24-08731-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5060/10218159/d0f8b4711907/ijms-24-08731-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5060/10218159/5ada8a4f77d4/ijms-24-08731-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5060/10218159/44190d606356/ijms-24-08731-g003.jpg

相似文献

1
CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.CD30 表达及其在成人 T 细胞白血病/淋巴瘤疾病进展中的作用。
Int J Mol Sci. 2023 May 13;24(10):8731. doi: 10.3390/ijms24108731.
2
Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.CD30 表达的里德 - 斯腾伯格细胞中 CD30 配体的自分泌生长调节:霍奇金淋巴瘤与间变性大细胞淋巴瘤的鉴别
Lab Invest. 2000 Jul;80(7):1111-9. doi: 10.1038/labinvest.3780117.
3
Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative.表达 CD30 和 CD15 的外周 T 细胞淋巴瘤扩大了间变性大细胞淋巴瘤、ALK 阴性的范围。
Br J Haematol. 2024 May;204(5):1862-1871. doi: 10.1111/bjh.19442. Epub 2024 Apr 12.
4
CD30 Characterizes Polylobated Lymphocytes and Disease Progression in HTLV-1-Infected Individuals.CD30 标记多叶形淋巴细胞并与 HTLV-1 感染者的疾病进展相关。
Clin Cancer Res. 2018 Nov 1;24(21):5445-5457. doi: 10.1158/1078-0432.CCR-18-0268. Epub 2018 Aug 1.
5
Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells.Galectin-1 介导的细胞死亡可被 CD30 诱导的信号转导增强,在间变大细胞淋巴瘤细胞中,但不在霍奇金淋巴瘤细胞中。
Lab Invest. 2012 Feb;92(2):191-9. doi: 10.1038/labinvest.2011.151. Epub 2011 Oct 10.
6
Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.细胞毒性蛋白在外周T细胞淋巴瘤和自然杀伤细胞(NK)淋巴瘤中的表达:与结外部位、NK或Tγδ表型、间变性形态及CD30表达的关系
Leuk Lymphoma. 2000 Jul;38(3-4):317-26. doi: 10.3109/10428190009087022.
7
Susceptibility of human T-cell leukemia virus type I-infected cells to humanized anti-CD30 monoclonal antibodies in vitro and in vivo.体外和体内人源化抗 CD30 单克隆抗体对人 T 细胞白血病病毒 I 感染细胞的敏感性。
Cancer Sci. 2010 Jan;101(1):224-30. doi: 10.1111/j.1349-7006.2009.01354.x. Epub 2009 Sep 8.
8
The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma.CD30 信号诱导的染色体不稳定性在成人 T 细胞白血病/淋巴瘤中的致癌驱动因素。
Cancer Sci. 2023 Apr;114(4):1556-1568. doi: 10.1111/cas.15706. Epub 2023 Jan 9.
9
Clinicopathological features of adult T-cell leukemia with CD30 antigen expression.伴有CD30抗原表达的成人T细胞白血病的临床病理特征
Leuk Lymphoma. 1994 Oct;15(3-4):303-10. doi: 10.3109/10428199409049728.
10
Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children.儿童CD25+间变性大细胞淋巴瘤中人嗜T细胞病毒分析。
Am J Clin Pathol. 2009 Jul;132(1):28-33. doi: 10.1309/AJCP6Q7QMUVGMVMF.

引用本文的文献

1
Molecular Insights into the Diagnosis of Anaplastic Large Cell Lymphoma: Beyond Morphology and Immunophenotype.间变性大细胞淋巴瘤诊断的分子见解:超越形态学和免疫表型
Int J Mol Sci. 2025 Jun 19;26(12):5871. doi: 10.3390/ijms26125871.
2
Antibody-Drug Conjugates (ADCs): current and future biopharmaceuticals.抗体药物偶联物(ADCs):当前及未来的生物制药
J Hematol Oncol. 2025 Apr 30;18(1):51. doi: 10.1186/s13045-025-01704-3.
3
Immunotherapy in chronic lymphocytic leukemia: advances and challenges.慢性淋巴细胞白血病的免疫疗法:进展与挑战

本文引用的文献

1
The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma.CD30 信号诱导的染色体不稳定性在成人 T 细胞白血病/淋巴瘤中的致癌驱动因素。
Cancer Sci. 2023 Apr;114(4):1556-1568. doi: 10.1111/cas.15706. Epub 2023 Jan 9.
2
Whole-genome landscape of adult T-cell leukemia/lymphoma.成人 T 细胞白血病/淋巴瘤的全基因组景观。
Blood. 2022 Feb 17;139(7):967-982. doi: 10.1182/blood.2021013568.
3
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.
Exp Hematol Oncol. 2025 Apr 10;14(1):53. doi: 10.1186/s40164-025-00644-5.
4
Immunological Features and Potential Biomarkers of Systemic Sclerosis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.系统性硬化症相关间质性肺疾病和特发性肺纤维化的免疫学特征及潜在生物标志物
Clin Respir J. 2025 Apr;19(4):e70072. doi: 10.1111/crj.70072.
5
Generation of antagonistic biparatopic anti-CD30 antibody from an agonistic antibody by precise epitope determination and utilization of structural characteristics of CD30 molecule.通过精确确定表位并利用CD30分子的结构特征,从一种激动性抗体生成拮抗性双表位抗CD30抗体。
Antib Ther. 2025 Jan 14;8(1):56-67. doi: 10.1093/abt/tbaf002. eCollection 2025 Jan.
6
Antibody-Drug Conjugates Targeting CD30 in T-Cell Lymphomas: Clinical Progression and Mechanism.靶向T细胞淋巴瘤中CD30的抗体药物偶联物:临床进展与机制
Cancers (Basel). 2025 Feb 2;17(3):496. doi: 10.3390/cancers17030496.
7
Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasms.开发一种针对T细胞受体TRBV5-1区段的重组人IgG1单克隆抗体,用于治疗成熟T细胞肿瘤。
Front Immunol. 2024 Dec 17;15:1520103. doi: 10.3389/fimmu.2024.1520103. eCollection 2024.
8
Identifying potential drug targets for myocardial infarction through Mendelian randomization.通过孟德尔随机化确定心肌梗死的潜在药物靶点。
PLoS One. 2024 Dec 23;19(12):e0313770. doi: 10.1371/journal.pone.0313770. eCollection 2024.
9
Cancer Biomarkers and Precision Oncology: A Review of Recent Trends and Innovations.癌症生物标志物与精准肿瘤学:近期趋势与创新综述
Clin Med Insights Oncol. 2024 Nov 17;18:11795549241298541. doi: 10.1177/11795549241298541. eCollection 2024.
10
Distinct soluble immune checkpoint profiles characterize COVID-19 severity, mortality and SARS-CoV-2 variant infections.不同可溶性免疫检查点特征可用于表征 COVID-19 严重程度、死亡率和 SARS-CoV-2 变异感染。
Front Immunol. 2024 Sep 23;15:1464480. doi: 10.3389/fimmu.2024.1464480. eCollection 2024.
基于超级增强子的 BATF3/IL-2R 模块鉴定揭示了间变大细胞淋巴瘤的弱点。
Nat Commun. 2021 Sep 22;12(1):5577. doi: 10.1038/s41467-021-25379-9.
4
Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma.原发性皮肤间变大细胞淋巴瘤的全基因组分析。
Haematologica. 2022 Jul 1;107(7):1619-1632. doi: 10.3324/haematol.2020.263251.
5
Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma.时序基因组和单细胞转录组整合分析揭示成人 T 细胞白血病/淋巴瘤的演化过程。
Nat Commun. 2021 Aug 10;12(1):4821. doi: 10.1038/s41467-021-25101-9.
6
A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma.在间变大细胞淋巴瘤中,一种新的非经典 NF-κB 通路激活模型。
Leukemia. 2021 Jul;35(7):1976-1989. doi: 10.1038/s41375-020-01088-y. Epub 2020 Nov 12.
7
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.日本成人 T 细胞白血病/淋巴瘤患者的预后:一项基于全国医院的研究。
Cancer Sci. 2020 Dec;111(12):4567-4580. doi: 10.1111/cas.14658. Epub 2020 Oct 21.
8
Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia/lymphoma diagnosis.逆转录病毒感染的前恶性 T 细胞克隆在成人 T 细胞白血病/淋巴瘤诊断前的演变。
Blood. 2020 Jun 4;135(23):2023-2032. doi: 10.1182/blood.2019002665.
9
Super-enhancer function and its application in cancer targeted therapy.超级增强子功能及其在癌症靶向治疗中的应用。
NPJ Precis Oncol. 2020 Feb 12;4:2. doi: 10.1038/s41698-020-0108-z. eCollection 2020.
10
Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells.慢性 CD30 信号在 B 细胞中导致淋巴癌的发生,其机制是驱动浆母细胞和 B1 细胞的扩增。
Blood. 2019 Jun 13;133(24):2597-2609. doi: 10.1182/blood.2018880138. Epub 2019 Apr 8.